
Groß war jedoch die Sorge, dass man dies in Dänemark nicht lange auf sich sitzen lassen würde. Mit Spannung wurden im Dezember ...Den vollständigen Artikel lesen ...
© 2024 NTG24.de
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
01:59 | Eli Lilly boss: 'Tariffs are pivotal moment and hard to come back from' | ||
Do | Eli Lilly to leverage Sangamo capsid technology for CNS disease therapies | ||
Do | Sangamo Therapeutics stock soars on Lilly licensing deal | ||
Do | Sangamo Therapeutics, Inc.: Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System | Agreement grants Lilly rights to employ Sangamo's novel proprietary capsid, STAC-BBB, for up to five potential disease targets Sangamo to receive an $18 million upfront license fee and... ► Artikel lesen | |
Do | DTC obesity med market heats up: Eli Lilly taps knownwell, Hims & Hers adds new weight loss meds to platform |